001     305638
005     20251109023656.0
024 7 _ |a 10.1002/mp.70106
|2 doi
024 7 _ |a pmid:41186921
|2 pmid
024 7 _ |a pmc:PMC12584934
|2 pmc
024 7 _ |a 0094-2405
|2 ISSN
024 7 _ |a 1522-8541
|2 ISSN
024 7 _ |a 2473-4209
|2 ISSN
024 7 _ |a altmetric:184124746
|2 altmetric
037 _ _ |a DKFZ-2025-02280
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Xiao, Fan
|b 0
245 _ _ |a Deep learning-based synthetic-CT-free photon dose calculation in MR-guided radiotherapy: A proof-of-concept study.
260 _ _ |a Hoboken, NJ
|c 2025
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1762420783_1579198
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a In magnetic resonance imaging (MRI)-guided online adaptive radiotherapy, MRI lacks tissue attenuation information necessary for accurate dose calculations. Although deep learning (DL)-based synthetic computed tomography (CT) generation models have been developed to obtain CT density information from MRI, they usually do not meet the requirement of real-time plan adaptation.We propose a DL-based photon dose calculation method directly on 0.35 T MRI to skip synthetic CT generation and show its feasibility for prostate patient cases.The 0.35 T planning MRI and deformed planning CT (registered to the planning MRI) of 34 prostate cancer patients treated with a 0.35 T magnetic resonance-linear accelerator (MR-Linac) were collected. The air cavities (ACs) in the abdominopelvic area of the deformed CT images were corrected based on manual AC contouring on the MRI. Monte Carlo (MC) dose simulations under a 0.35 T magnetic field were performed on the corrected CT images. All photon beams were simulated using a uniform field size of 1 cm × 1 cm $1\,\text{cm} \times 1\,\text{cm}$ . 10 800 beams were simulated with 5 × 10 6 $5\times 10^6$ initial photons for training (20 patients) and 2160 beams with 5 × 10 7 $5\times 10^7$ photons for validation (4 patients). For testing, 1080 beams shooting through the planning target volume (PTV) in 10 patients and five optimized nine-field intensity-modulated plans were simulated with 5 × 10 7 $5\times 10^7$ photons. 3D MRI cuboids covering the photon beams were input into a Unet model to predict AC segmentation, and 3D MRI and predicted AC cuboids were input into a long short-term memory (LSTM) model for beam's eye view (BEV) processing to predict dose. The gamma passing rate γ pr $\gamma _{\mathrm{pr}}$ (2%/2mm, D > 10 % D max $D>10\%D_{\mathrm{max}}$ ), beam dose profiles of single beams and dose volume histogram (DVH) of intensity-modulated plans were evaluated.The test results for all photon beams from the proposed models demonstrated a mean γ pr $\gamma _{\mathrm{pr}}$ above 99.50%. The five treatment plans recalculated by the DL model each achieved γ pr $\gamma _{\mathrm{pr}}$ values exceeding 99.80%. Additionally, the model's inference time was approximately 12 ms per photon beam.The proposed method showed that DL-based dose calculation directly on MRI is feasible for prostate cases, which has the potential to simplify the procedure for MRI-only workflows and can be beneficial for real-time plan adaptation.
536 _ _ |a 315 - Bildgebung und Radioonkologie (POF4-315)
|0 G:(DE-HGF)POF4-315
|c POF4-315
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a LSTM
|2 Other
650 _ 7 |a MRI
|2 Other
650 _ 7 |a deep learning
|2 Other
650 _ 7 |a dose calculation
|2 Other
650 _ 7 |a online MR‐guided photon therapy
|2 Other
650 _ 2 |a Deep Learning
|2 MeSH
650 _ 2 |a Radiotherapy, Image-Guided: methods
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
650 _ 2 |a Photons: therapeutic use
|2 MeSH
650 _ 2 |a Radiotherapy Planning, Computer-Assisted: methods
|2 MeSH
650 _ 2 |a Proof of Concept Study
|2 MeSH
650 _ 2 |a Radiotherapy Dosage
|2 MeSH
650 _ 2 |a Prostatic Neoplasms: radiotherapy
|2 MeSH
650 _ 2 |a Prostatic Neoplasms: diagnostic imaging
|2 MeSH
650 _ 2 |a Radiation Dosage
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Monte Carlo Method
|2 MeSH
650 _ 2 |a Tomography, X-Ray Computed
|2 MeSH
700 1 _ |a Radonic, Domagoj
|b 1
700 1 _ |a Wahl, Niklas
|0 P:(DE-He78)dfd5aaf608015baaaed0a15b473f1336
|b 2
|u dkfz
700 1 _ |a Delopoulos, Nikolaos
|b 3
700 1 _ |a Thummerer, Adrian
|b 4
700 1 _ |a Corradini, Stefanie
|b 5
700 1 _ |a Belka, Claus
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Dedes, George
|b 7
700 1 _ |a Kurz, Christopher
|b 8
700 1 _ |a Landry, Guillaume
|b 9
773 _ _ |a 10.1002/mp.70106
|g Vol. 52, no. 11, p. e70106
|0 PERI:(DE-600)1466421-5
|n 11
|p e70106
|t Medical physics
|v 52
|y 2025
|x 0094-2405
909 C O |o oai:inrepo02.dkfz.de:305638
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)dfd5aaf608015baaaed0a15b473f1336
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-HGF)0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-315
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Bildgebung und Radioonkologie
|x 0
914 1 _ |y 2025
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2024-12-13
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2024-12-13
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-13
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MED PHYS : 2022
|d 2024-12-13
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2024-12-13
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2024-12-13
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2024-12-13
920 1 _ |0 I:(DE-He78)E040-20160331
|k E040
|l E040 Med. Physik in der Strahlentherapie
|x 0
920 1 _ |0 I:(DE-He78)MU01-20160331
|k MU01
|l DKTK Koordinierungsstelle München
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)E040-20160331
980 _ _ |a I:(DE-He78)MU01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21